Publications Database

Self T. L. , Hale L. S. , Crumrine D. (2010)

Pharmacotherapy and children with autism spectrum disorder: A tutorial for speech-language pathologists.

Language, Speech, and Hearing Services in Schools

41 pp. 367-375.

Read Abstract (New Window)

Serrano. A. (1981)

Haloperidol: its use in children.

Journal of Clinical Psychiatry

42(4), pp. 154-156

Read Abstract (New Window)

Shea S. et al. (2004)

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Pediatrics

114(5), e. 634-641

Read Abstract (New Window) Read Full (New Window)

Sokhadze E. M. et al.

Electrophysiological and behavioral outcomes of Berard auditory integration training (AIT) in children with autism spectrum disorder.

Applied Psychophysiological and Biofeedback

Read Abstract (New Window)

Srinivasan S. M. , Cavagnino D. T. , Bhat A. N. (2018)

Effects of equine therapy on individuals with autism spectrum disorder: A systematic review.

Review Journal of Autism and Developmental Disorders

June, 5(2), pp .156–175.

Read Abstract (New Window)

Stachnik J. M. , Nunn-Thompson C. (2007)

Use of atypical antipsychotics in the treatment of autistic disorder.

Annals of Pharmacotherapy

41(4), pp. 626-634

Read Abstract (New Window)

Stephenson J. , Carter M. (2008)

The use of weighted vests with children with autism spectrum disorders and other disabilities.

Journal of Autism and Developmental Disorders

39(1), pp. 105-114

Read Abstract (New Window) Read Full (New Window)

Sturm H. , Fernell E. , Gillberg C. (2004)

Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups.

Developmental Medicine and Child Neurology

46(7), pp. 444-447

Read Abstract (New Window)

Sturman N. , Deckx L. , van Driel M. L. (2017)

Methylphenidate for children and adolescents with autism spectrum disorder.

Cochrane Database of Systematic Reviews

(11),

Read Abstract (New Window) Read Full (New Window)

Tanguay P. E. (2000)

Pervasive developmental disorders: a 10-year review.

Journal of the American Academy of Child and Adolescent Psychiatry

39(9), pp. 1079-1095

Read Abstract (New Window)

Troost P. et al. (2006)

Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.

Journal of Child and Adolescent Psychopharmacology

pp. 611-619

Read Abstract (New Window)

Tuchman R. F. (2004)

AEDs and psychotropic drugs in children with autism and epilepsy.

Mental Retardation and Developmental Disabilities Research Reviews

10(2), pp. 135-138

Read Abstract (New Window)

Valicenti-McDermott M. R. et al. (2014)

Use of complementary and alternative medicine in children with autism and other developmental disabilities: Associations with ethnicity, child comorbid symptoms, and parental stress.

Journal of Child Neurology

29(3), pp. 360-367.

Read Abstract (New Window)

Viscidi E. W. et al. (2014)

The association between epilepsy and autism symptoms and maladaptive behaviors in children with autism spectrum disorder.

Autism

November, 18(8), pp. 996-1006.

Read Abstract (New Window)

Wang Y. et al. (2016)

Heart rate variability and skin conductance during repetitive TMS course in children with autism.

Applied Psychophysiological and Biofeedback

March, 41(1), pp.47-60.

Read Abstract (New Window)

Ward F. et al. (2013)

Efficacy of beta blockers in the management of problem behaviours in people with intellectual disabilities: a systematic review.

Research in Developmental Disabilities

12, 34 pp. 4293-4303.

Read Abstract (New Window)

Wasserman S. et al. (2006)

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

International Clinical Psychopharmacology

21(6), pp. 363-367

Read Abstract (New Window)

Wender E. (1986)

The food additive-free diet in the treatment of behavior disorders: a review.

Journal of Developmental and Behavioral Pediatrics

February, 7(1), pp. 35-42.

Read Abstract (New Window)

Whitely P. et al. (2013)

Gluten- and casein-free dietary intervention for autism spectrum conditions.

Frontiers in Human Neuroscience

Read Full (New Window)

Willemsen-Swinkels S. H. et al. (1999)

Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.

Journal of Autism and Developmental Disorders

29(2), pp. 167-169

Read Abstract (New Window)